SK19495A3 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions Download PDF

Info

Publication number
SK19495A3
SK19495A3 SK194-95A SK19495A SK19495A3 SK 19495 A3 SK19495 A3 SK 19495A3 SK 19495 A SK19495 A SK 19495A SK 19495 A3 SK19495 A3 SK 19495A3
Authority
SK
Slovakia
Prior art keywords
benzylidene
piperazinedione
compound
methyl
dimethyl
Prior art date
Application number
SK194-95A
Other languages
English (en)
Slovak (sk)
Inventor
Mark A D Collins
Maria I Chicarelli-Robinson
Justin S Bryans
Christopher J Latham
Stephen J Brocchini
Original Assignee
Xenova Limited British Body Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Limited British Body Co filed Critical Xenova Limited British Body Co
Publication of SK19495A3 publication Critical patent/SK19495A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK194-95A 1992-08-14 1993-08-16 Pharmaceutical compositions SK19495A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929217331A GB9217331D0 (en) 1992-08-14 1992-08-14 Pharmaceutical compounds
PCT/GB1993/001735 WO1994004513A1 (en) 1992-08-14 1993-08-16 Pharmaceutically active diketopiperazines

Publications (1)

Publication Number Publication Date
SK19495A3 true SK19495A3 (en) 1995-11-08

Family

ID=10720385

Family Applications (2)

Application Number Title Priority Date Filing Date
SK194-95A SK19495A3 (en) 1992-08-14 1993-08-16 Pharmaceutical compositions
SK195-95A SK19595A3 (en) 1992-08-14 1993-08-16 Diketopiperazines, method of their preparation, use and pharmaceutical agent which containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK195-95A SK19595A3 (en) 1992-08-14 1993-08-16 Diketopiperazines, method of their preparation, use and pharmaceutical agent which containing them

Country Status (24)

Country Link
US (1) US5700804A (ko)
EP (2) EP0655060B1 (ko)
JP (2) JPH08504175A (ko)
KR (2) KR950702967A (ko)
AT (1) ATE162186T1 (ko)
AU (2) AU678172B2 (ko)
BG (2) BG99495A (ko)
BR (2) BR9306905A (ko)
CA (2) CA2141938A1 (ko)
CZ (2) CZ38195A3 (ko)
DE (1) DE69316370T2 (ko)
DK (1) DK0655060T3 (ko)
ES (1) ES2111169T3 (ko)
FI (2) FI950617A (ko)
GB (2) GB9217331D0 (ko)
GR (1) GR3026272T3 (ko)
HU (2) HUT71592A (ko)
IL (2) IL106695A0 (ko)
PL (2) PL307438A1 (ko)
RU (2) RU95108759A (ko)
SK (2) SK19495A3 (ko)
TW (1) TW334427B (ko)
WO (2) WO1994004512A1 (ko)
ZA (2) ZA935968B (ko)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
DK85193D0 (da) 1993-07-16 1993-07-16 Cancerforskningsfondet Af 1989 Suppression of inhibitors
GB9402805D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
IL112627A0 (en) * 1994-02-14 1995-05-26 Xenova Ltd Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
GB9402809D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds
GB9426224D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB2310854B (en) * 1994-12-23 1998-09-09 Xenova Ltd Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
GB9426071D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB9426090D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB2311781B (en) * 1994-12-23 1998-09-16 Xenova Ltd Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
US5891877A (en) * 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds
JP2003515590A (ja) * 1999-12-03 2003-05-07 エモリー ユニバーシティ 癌を処置するためのクルクミンアナログ
KR100852965B1 (ko) * 2000-05-09 2008-08-19 애드파르마 인코포레이티드 피페라진디온 화합물
US7288545B2 (en) 2000-05-09 2007-10-30 Angiorx Corporation Piperazinedione compounds
ES2381775T3 (es) 2000-08-04 2012-05-31 Dmi Biosciences, Inc. Procedimiento del uso de dicetopiperazinas y composición que las contiene
WO2002020663A2 (en) 2000-09-06 2002-03-14 Ap Pharma, Inc. Degradable polyacetal polymers
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6815214B2 (en) 2000-12-29 2004-11-09 Celltech R & D, Inc. Pharmaceutical uses and synthesis of diketopiperazines
GB2372740A (en) * 2001-01-17 2002-09-04 Xenova Ltd Diketopiperazines
AU2003220091B2 (en) * 2002-03-08 2006-02-16 Emory University Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
KR101049100B1 (ko) 2002-08-02 2011-07-15 니리어스 파마슈티컬즈, 인코퍼레이션 데하이드로페닐아히스틴 및 그의 동족체, 및 이들의 합성방법
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
DE10238144A1 (de) * 2002-08-15 2004-02-26 Basf Ag Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
WO2004030522A2 (en) * 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
AU2004241101B2 (en) 2003-05-15 2010-05-13 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
GB0314738D0 (en) 2003-06-24 2003-07-30 Glaxo Group Ltd Novel compounds
WO2006105051A2 (en) * 2005-03-29 2006-10-05 Nereus Pharmaceuticals, Inc. Synthesis of diketopiperazines
US20070270464A1 (en) * 2006-02-24 2007-11-22 Emory University Prodrugs of curcumin analogs
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
WO2012033792A2 (en) 2010-09-07 2012-03-15 Dmi Acquisition Corp. Treatment of diseases
EP2673265B1 (en) * 2011-02-10 2016-10-19 MannKind Corporation Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ，インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
WO2013055734A1 (en) 2011-10-10 2013-04-18 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
AU2012328605B9 (en) 2011-10-28 2017-08-03 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
SG11201506267XA (en) 2013-03-15 2015-09-29 Ampio Pharmaceuticals Inc Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
CN105272968B (zh) * 2014-06-10 2018-03-13 首都医科大学 (3s,6r)‑3,6二取代哌嗪‑2,5‑二酮,其制备及应用
CA2958080A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN104610170B (zh) * 2015-01-14 2017-02-01 中国科学院南海海洋研究所 2,5‑二酮哌嗪衍生物及其制备方法和应用
US10238650B2 (en) 2015-03-06 2019-03-26 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a RAS mutation
CA2978679A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW MOLECULAR WEIGHT HUMAN SERUM ALBUMIN FRACTIONS FOR TREATING DISEASES
WO2017011399A1 (en) 2015-07-13 2017-01-19 Beyondspring Pharmaceuticals, Inc Plinabulin compositions
IL260933B2 (en) 2016-02-08 2023-04-01 Beyondspring Pharmaceuticals Inc Preparations containing tocorsol or its analogues
EP3463337A4 (en) 2016-06-06 2020-02-12 Beyondspring Pharmaceuticals, Inc. COMPOSITION AND METHOD FOR REDUCING NEUTROPENIA
CN110431135A (zh) 2017-01-06 2019-11-08 大连万春布林医药有限公司 微管蛋白结合化合物及其治疗用途
CA3052190A1 (en) 2017-02-01 2018-08-09 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
CN110054619A (zh) * 2018-01-18 2019-07-26 西北农林科技大学 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂
BR112020014960A2 (pt) 2018-01-24 2020-12-22 Beyondspring Pharmaceuticals, Inc. Composição e método para redução de trombocitopenia
WO2021195265A1 (en) 2020-03-24 2021-09-30 Ampio Pharmaceuticals, Inc. Methods for treating diseases associated with respiratory viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE621862C (de) * 1932-07-01 1935-11-14 Guenther Schiemann Dr Verfahren zur Darstellung von Kondensationsprodukten kernfluorierter Arylaldehyde
BE584914A (ko) * 1958-11-24
JPS5747357A (en) * 1980-09-04 1982-03-18 Ricoh Co Ltd Novel disazo compound and its preparation
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CZ38195A3 (en) 1995-09-13
DK0655060T3 (da) 1998-02-09
RU95108759A (ru) 1996-12-10
JPH08504176A (ja) 1996-05-07
WO1994004513A1 (en) 1994-03-03
IL106696A0 (en) 1993-12-08
FI950617A0 (fi) 1995-02-13
AU693420B2 (en) 1998-07-02
BR9306905A (pt) 1998-12-08
HU9500436D0 (en) 1995-04-28
GB9217331D0 (en) 1992-09-30
CZ38395A3 (en) 1995-10-18
SK19595A3 (en) 1995-09-13
FI950617A (fi) 1995-04-13
BG99496A (en) 1995-12-29
DE69316370D1 (de) 1998-02-19
ATE162186T1 (de) 1998-01-15
BR9306904A (pt) 1998-12-08
PL307437A1 (en) 1995-05-29
FI950616A0 (fi) 1995-02-13
KR950702967A (ko) 1995-08-23
ZA935968B (en) 1995-02-16
IL106695A0 (en) 1993-12-08
EP0672036A1 (en) 1995-09-20
GB2284420A (en) 1995-06-07
EP0655060B1 (en) 1998-01-14
CA2141938A1 (en) 1994-03-03
HUT71592A (en) 1996-01-29
CA2141939A1 (en) 1994-03-03
FI950616A (fi) 1995-04-13
EP0655060A1 (en) 1995-05-31
AU4726493A (en) 1994-03-15
GB2284420B (en) 1996-09-25
HU9500437D0 (en) 1995-04-28
US5700804A (en) 1997-12-23
AU4726593A (en) 1994-03-15
BG99495A (en) 1995-12-29
JPH08504175A (ja) 1996-05-07
HUT71593A (en) 1996-01-29
ES2111169T3 (es) 1998-03-01
GR3026272T3 (en) 1998-06-30
GB9502859D0 (en) 1995-04-05
PL307438A1 (en) 1995-05-29
KR950702968A (ko) 1995-08-23
ZA935969B (en) 1995-02-16
AU678172B2 (en) 1997-05-22
RU95108387A (ru) 1996-12-10
DE69316370T2 (de) 1998-07-16
WO1994004512A1 (en) 1994-03-03
TW334427B (en) 1998-06-21

Similar Documents

Publication Publication Date Title
SK19495A3 (en) Pharmaceutical compositions
JP6228130B2 (ja) 治療活性化合物およびそれらの使用方法
RU2728827C2 (ru) Кристаллическая форма ингибитора тирозинкиназы брутона и способ её получения
EP2964223B1 (en) Compounds inhibiting leucine-rich repeat kinase enzyme activity
US5852018A (en) Pharmaceutical piperazine compounds
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
JP2018519249A (ja) イソオキサゾリル置換ベンズイミダゾール類
KR101569261B1 (ko) 암을 치료하기 위한 hdac 억제제로서 4-아미노-n-하이드록시-벤즈아미드
EA022341B1 (ru) Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена
WO2003041641A2 (en) Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
TW200815387A (en) Chromen-2-one derivatives
JP2593273B2 (ja) 置換ジアミノフタルイミドおよび同族体
SK83697A3 (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
WO2018005801A2 (en) Novel non-systemic tgr5 agonists
KR20130086608A (ko) 암 치료용 신규 ｎ-하이드록시-벤즈아마이드
KR100412167B1 (ko) 다중약물내성의조절제로서의피페라진-2,5-디온유도체
JP5330377B2 (ja) ３，４−ジヒドロキナゾリン誘導体
AU2114600A (en) Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
US20220267289A1 (en) Selective bcrp/abcg2 transporter inhibitors as agents to abolish resistance to anti-cancer agents
US5861400A (en) Pharmaceutical compounds
WO2016127949A1 (zh) 作为t790变异抑制剂的嘧啶衍生物
CN115052855A (zh) 酰胺化合物的制备方法、其晶型及其盐类
US20190240244A1 (en) Compounds for cancer chemotherapeutic sensitization
EP4317143A1 (en) Bicyclic heterocyclic fgfr4 inhibitor, pharmaceutical composition and preparation comprising same, and application thereof
KR20230171449A (ko) 브루톤 티로신 키나제 억제제의 공결정질 형태